Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Oxygen Therapeutic NanO2 for Mild Respiratory Distress in Phase 1b

NCT06658535 is registered in ClinicalTrials.gov with NuvOx LLC as lead sponsor.

NCT NCT06658535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06658535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Oxygen Therapeutic NanO2 for Mild Respiratory Distress in Phase 1b
Lead sponsor
NuvOx LLC
Phase
Phase 1
Overall status
Recruiting
Start date
March 13, 2025
Completion date
December 31, 2026
Enrollment
18 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mild respiratory distress